Episodes
-
Which decisions are made at Region level in the NHS in England? How do finances and funding work at this level? And how can industry best support and engage with Region leaders?
We sit down with guest speaker Richard Smale (Interim Director of System Co-ordination, NHS England [NHSE] â South West) for an all-encompassing discussion that explored finance, funding flows, system priorities, and the decision-making process in NHS Regions.
Richard heads up system co-ordination work across the NHS South West Region. The Region has seven Integrated Care Boards (ICBs), 22 Trusts, nine counties and a resident population of over 5.5 million patients stretching from Gloucestershire and Wiltshire to the Isles of Scilly.
The interview was led by David Thorne (Principal Consultant, Mtech Access and Transformation Director at Well Up North Primary Care Network [PCN]) who put both the NHS and industry perspectives to Richard to explore the real state of the NHS.
In this episode, David and Richard discuss:
- Where the NHS is heading and what this means for your strategy and business planning
- Decision making, finances, and funding flows across the NHS
- The role of NHS Regions, particularly with key funding decisions like Specialised Commissioning
- Delivering service change across integrated systems
- Policy priorities in practice and what to expect in an election year
- How Pharma, Medtech, and Diagnostics companies can best engage NHS leaders at Region level
This episode was first broadcast as a live webinar in February 2024.
Learn more about the webinar and Richard at: https://mtechaccess.co.uk/how-does-funding-flow-in-nhse-regions/
Discover more about our NHS Insights services at: https://mtechaccess.co.uk/uk-nhs-insights/Subscribe to our newsletter to hear more news, insights and events from Mtech Access.
-
What do we know about plans and policy for 2024/25? As the expected central operating plan had not materialised (at time of recording), and with a general election and a potential Labour government on the horizon, how can NHS and industry drive forward improvements and innovation?
Host Robert Hull (Senior Consultant â NHS Insight & Interaction, Mtech Access) was joined by guest speakers Debbie Morgan (Director of Service Improvement and Transformation, Cambridge University Hospitals NHS Foundation Trust), Ellen Rule (Deputy CEO/Director of Strategy & Transformation, Gloucestershire Integrated Care Board) and Dr Viren Mehta (GP Partner, GP Federation Chief Officer, Viaduct Care). Together we explored what all this uncertainty means for NHS decision-making, day-to-day operations, strategy, and engagement with industry.
In this webinar, we bring together leaders from across the NHS to explore how they are planning and operating in this uncertainty.
We explore:
- Strategy and planning in these times of uncertainty
- Whatâs happening with GP contracts
- Financial pressures and challenges
- If/where itâs possible to drive forward change in the current environment
- How Pharma and Medtech can best support NHS leaders
- Where the panel would welcome solutions from industry
Please note this episode was first broadcast in January 2024 as a live webinar. Some aspects of policy discussed have evolved and continue to evolve.
Discover more at: https://mtechaccess.co.uk/nhs-policy-for-2024-25/
Learn more about our NHS insights services at: https://mtechaccess.co.uk/uk-nhs-insights/Subscribe to our newsletter to hear more news, insights and events from Mtech Access.
-
Missing episodes?
-
What is health economic evaluation and which modelling approaches can be used to support market access activities?
In this episode, our expert health economists explain the key strengths and limitations of the most common health economic modelling classifications and structures. Here, Hannah Gillies (Consultant â Health Economics) and Daniel MacDonald (Associate Consultant â Health Economics) de-mystify the different approaches to health economic modelling.
Our specialists explore six of the most common health economic modelling structures used to support market access activities;
- Decision trees
- Markov models
- Semi-Markov models
- Partitioned survival models
- Cox regression models
- Discrete event simulations
This episode was first broadcast as a live webinar in January 2024. For more information or to request a copy of the slides used, please visit: https://mtechaccess.co.uk/de-mystifying-health-economic-models/
Work with our health economists: https://mtechaccess.co.uk/health-economics/Subscribe to our newsletter to hear more news, insights and events from Mtech Access.
-
Here, our experts explore evidence strategies for medical devices, diagnostics and digital health technologies.
Have you established the clinical and economic value of your medical device, diagnostic or digital technology? Do you have the evidence required to support your value proposition? Would a health technology assessment (HTA) route be appropriate for your product? What will payers, HTA agencies, and other key decision makers be looking for? And how should this information be presented?
In this episode, our experts in HTA, health economics, and commercialisation explore:
- How to identify and communicate the value of your product for patients and the wider healthcare system
- How to build a robust evidence package for successful launch and commercialisation
- Key requirements for the National Institute for Health and Care Excellence (NICE) Medical Technologies Evaluation Programme (MTEP) or Diagnostics Assessment Programme (DAP)
- Next steps to take your innovation to healthcare leaders across the NHS and beyond, with an impactful customer communication strategy
This episode was first broadcast as a live webinar in January 2023. Learn more and request a copy of the slides at: https://mtechaccess.co.uk/evidence-strategy-for-medical-technologies-and-diagnostics/
Discover how Mtech Access can support your commercialisation journey at: https://mtechaccess.co.uk/medical-device-market-access/Subscribe to our newsletter to hear more news, insights and events from Mtech Access.
-
How can you ensure your product is set up for success from early clinical trials right through to launch and commercialisation? In this Global Whispers webinar we explore best practice commercialisation strategy for healthcare products launching in the US market.
Clare Foy (Director â Global Market Access, Mtech Access) speaks to Janice MacLennan (Pharma and Medtech brand strategist and founder of NMBLR) about how market access, HEOR and commercialisation leads in Pharma and Medtech can best support overarching product and brand strategy, with a focus on launch challenges in the US market.
We take a step back from the intricacies of market access and HEOR, to explore the role our specialism plays in broader commercial and product strategy. We ask: where does market access and HEOR sit in this broader picture, and how can market access teams best support their product and company brand?
Using the US market as our case study, we explore:
- How to set up your product for success
- Commercialisation routes in the US for Pharma and Medtech
- The relationship between brand strategy and market access
- What Pharma can learn from Medtechâs approach to commercialisation
- What Medtech innovators can learn from Pharma companiesâ approach to launch
This episode was first broadcast as a live webinar in January 2024.
Learn more at: https://mtechaccess.co.uk/commercialisation-strategy-us-market/
Explore our work in the US market: https://mtechaccess.co.uk/launching-healthcare-products-in-the-us/
Discover how Mtech Access can support you global market access and pricing strategy: https://mtechaccess.co.uk/global-market-access-and-pricing/Subscribe to our newsletter to hear more news, insights and events from Mtech Access.
-
Whatâs happening with specialised commissioning in the NHS? How likely is a delay in delegation to integrated care boards (ICBs)? How and what should Pharma and Medtech plan for amidst all this uncertainty?
Specialised commissioning in the NHSThe risks and opportunities that devolution to ICBs will bringWhat we can expect to see in the short and longer termHow industry can support ICB leaders through this transitionHow Pharma, Medtech, and Diagnostics companies, whose products come under specialised commissioning, can manage these risks and uncertainties
Malcolm Qualie (former Medicines Lead for Specialised Services, NHS England) speaks to David Thorne (Principal Associate, Mtech Access) to explore specialised commissioning in the NHS and what to expect as we head into 2024.
Malcolm Qualie and David Thorne explored:
Learn more at https://mtechaccess.co.uk/nhs-specialised-commissioning/
This episode first broadcast as a live webinar in Decmeber 2023.Subscribe to our newsletter to hear more news, insights and events from Mtech Access.
-
What does it take to run a truly patient-centric integrated health system? What does the Welsh journey with integration tell us about the future for England?
Paul Mears (CEO, Cwm Taf Morgannwg University Health Board) joins Robert Hull (Senior Consultant â NHS Insight & Interaction, Mtech Access) to explore the integrated care model in Wales and the lessons England can take from the Welsh experience.
In this NHS Whispers webinar, guest speaker Paul Mears shares his experiences leading a Welsh health board. The 7 Health Boards in Wales have been operating as integrated systems for over a decade. With the NHS in England just getting to grips with integration, we explore what England can learn from the Welsh experience.
Robert and Paul explore:
- How NHS Wales is structured and who the key decision makers are
- How the integrated healthcare system works in Wales and how this differs to whatâs happening in England
- How priorities are set and what shapes decision-making at health board level
- The nuances of the Welsh health system and what this means for industry
- How Welsh Health Boards work with industry and the lessons here for ICBs and industry in England
- Prudent healthcare and what this means in practice
- How industry can best engage with health board leaders, what channels to use, and what messages to bring
This episode was first broadcast live as webinar in November 2023
Learn more about this webinar at: https://mtechaccess.co.uk/integrated-care-in-nhs-wales/
Discover how we can help you with your NHS engagement and UK market access strategy at: https://mtechaccess.co.uk/uk-nhs-insights/Subscribe to our newsletter to hear more news, insights and events from Mtech Access.
-
Clare Foy (Director â Global Market Access, Mtech Access) speaks to Italian market access expert Prof. Fabrizio Gianfrate (Professor of Health Economics and Outcomes Research [HEOR] and Ex-Payer) about the market access landscape in Italy, particularly regarding changes at the Agenzia Italiana del Farmaco (AIFA).
We explore:
- The nature of the Italian market and the reimbursement process
- Pricing and market access considerations when launching in Italy
- What the reforms at AIFA mean for market access and managed entry agreements
- How the AIFA changes specifically impact innovative products
- Changes to early access programmes in Italy
- Impact of these changes on international pricing, particularly with the introduction of the EU Joint Clinical Assessment (JCA)
This episode was first broadcast as a live webinar in October 2023. Learn more at: https://mtechaccess.co.uk/italy-market-access-aifa-reforms/Subscribe to our newsletter to hear more news, insights and events from Mtech Access.
-
Dr Farzana Hussain (GP Principal, The Project Surgery) and Prof. Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) explore the unmet needs of Primary Care Networks (PCNs) and how industry can best support primary care leaders and GPs as we head into winter, 2024 and beyond.
How unmet needs are identified in primary care, the processes followed, and datasets used to inform decision making The specific challenges facing primary care as we head into winter The role of PCN leaders and their impact on national policy How industry can best support and collaborate with PCNs Ongoing lessons from the pandemic and the vaccine roll-out
Former âGP of the yearâ and strategic influencer over primary care policy, Dr Farzana Hussain, discusses the unmet needs in primary care, how primary care leaders are responding to these challenges, and where industry can best offer support.
Phil and Farzana discuss:
Learn more about this webinar at: https://mtechaccess.co.uk/unmet-need-nhs-primary-care/
Discover or NHS Insight and UK market access services: https://mtechaccess.co.uk/uk-nhs-insights/
This episode was first broadcast as a live webinar in October 2023.Subscribe to our newsletter to hear more news, insights and events from Mtech Access.
-
How can our community support NHS leaders to deliver a data-led, people-centric health service?
Dr Mark Davies (Global Chief Health Officer, IBM) joins Prof. Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) to explore the power of data, the role of community and how the health and life sciences ecosystem can support the NHSâs population health management goals.
Population health management has the potential to be a powerful tool for healthcare systems, effecting the way health and care is strategised, budgeted, targeted, and delivered. We see a future where key decisions in the NHS are driven by population health data. What we now need is a new way of working powered by local need, quality evidence and a systematic approach.
In this webinar, Phil and Mark explore:
- How the NHS can use population health management to transform the system
- The importance of community in population health management
- How Pharma, Medtech, and the wider life sciences sector can work above brand to support the NHS with population health management
- What a data-driven, people-centric approach means for the way treatments are valued
- How population health management could transform the economics of healthcare
This episode was first broadcast as a live webinar on Friday 8th September 2023. Learn more at: https://mtechaccess.co.uk/uk-nhs-insights/
Discover more about our work in this area at: https://mtechaccess.co.uk/uk-nhs-insights/Subscribe to our newsletter to hear more news, insights and events from Mtech Access.
-
How is Artificial Intelligence being used in the development of new medicines? What role can AI currently play in clinical trials? Where can AI bridge gaps and solve challenges? What could this mean for the future of market access?
In this webinar, Dr George Magrath explains how his team at Lexitas are using AI in clinical trials in the field of ophthalmology. George and Calum explore:
- How, when and where AI is being used in clinical trials
- How Lexitas are using AI in clinical trials for ophthalmology
- Where AI may offer solutions to existing obstacles in clinical trials and ophthalmic drug development
- What the future holds for AI in the development of new medicines
- The role AI can play in selecting patients for clinical trials
- The impact AI may have on the way we evaluate drug effectiveness
- What this all means for evidence synthesis, health economics, reimbursement and market access
- The future prospects of AI in pharmaceutical development
Learn more at: https://mtechaccess.co.uk/ai-clinical-trials-evidence/
This episode was first broadcast as a live webinar in August 2023.Subscribe to our newsletter to hear more news, insights and events from Mtech Access.
-
How is the UK political landscape evolving and what does this mean for Health Technology and Medical Device innovators?
MHRA and new medical device regulatory regimeUK health and social care supply and procurementSustainability and social valueAddressing capacity challenges with effective health and social care packagesInnovationExport and import â the implications of Brexit
Robert Hull (Senior Consultant â NHS Insight & Interaction, Mtech Access) speaks to William Lee (Head of Policy and Compliance, British Healthcare Trades Association [BHTA]) about health policy, regulation and its implications for Medtech, Health technologies, and Medical Device market access.
With the challenges of the pandemic and the changes brought in following Brexit, policy and compliance in the UK has been on shifting sands for several years now. With many predicting a change in government at the next election, this continues to be a time of uncertainty. What does this political landscape mean for health policy, the regulatory regime and market access?
In this on-demand webinar, Rob asks Bill about 6 areas where Medtech should be paying attention:
This episode was first broadcast as a live webinar in July 2023. Learn more about this webinar at: https://mtechaccess.co.uk/uk-health-policy-medtech-bhta-webinar/
Learn more about our services for Medtech companies at: https://mtechaccess.co.uk/medical-device-market-access/Subscribe to our newsletter to hear more news, insights and events from Mtech Access.
-
Here we explore market access challenges in Germany, Austria and Switzerland. Clare Foy (Global Market Access Director â Mtech Access) speaks to Dr Stefan Walzer (CEO, President & Founder at MArS Market Access & Pricing Strategy GmbH) about the challenges and opportunities for reimbursement in the German-speaking markets.
Clare and Stefan discuss:
- Preparing for access to Switzerland â a European market outside the EU
- Pricing strategy and HTA decision-making in Austria under the new Ludwig Boltzmann Institute for Health Technology Assessment (LBI-HTA)
- Launching in Germany â is this still one of the most attractive European markets?
- The Financial Stabilisation Act in Germany â what this means for drug pricing
Learn more at: https://mtechaccess.co.uk/market-acce...
This episode was first broadcast as a live webinar in July 2023.Subscribe to our newsletter to hear more news, insights and events from Mtech Access.
-
How are nursing professionals supporting the digital evolution in UK healthcare? How can new technologies be leveraged by front-line clinical teams to support improved patient care? And how can Medtech, Digital and Biotech innovators collaborate with the front-line nursing teams in the NHS to drive transformation?
Prof. Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) speaks to Jennie Smith, registered nurse, Medtech launch specialist and our new Director of NHS Insight & Interaction at Mtech Access.
Phil and Jennie explore:
- The transformative power of technology in the NHS; particularly on patient pathways
- The role of nurses in digital transformation and the adoption and implementation of new technologies
- Key nursing champions, including Chief Nurse Information Officers (CNIOs)
- How industry can best support the NHS with digital transformation
- Our plans to bring together NHS and industry for greater collaboration
This episode was originally broadcast as a live webinar in June 2023. Learn more at: https://mtechaccess.co.uk/nursing-driving-digital-change-nhs/
Learn more about our NHS Insight & Interaction services at: https://mtechaccess.co.uk/uk-nhs-insights/Subscribe to our newsletter to hear more news, insights and events from Mtech Access.
-
In this Global Whispers webinar we explore market access for digital therapeutics. Clare Foy (Global Market Access Director â Mtech Access) speaks to Shefali Shah (Global VP, Market Value and Commercial Effectiveness â MindMaze) about the challenges and opportunities for digital therapies to gain market access and ultimately improve patient outcomes.
The opportunities for digital technologies in neurology and how they may impact existing care pathways in the futureHow the digital technology market differs from the pharmaceutical marketRegulatory and reimbursement challenges for digital technologiesHer experiences in launching digital technologies in markets such as the US and GermanyHow digital technologies can be used to enhance and complement existing treatments/pathways of careLessons other digital health, medical device and pharmaceutical companies can learn from Shefaliâs experiences
In the webinar, Clare asks Shefali about:
The episode was first broadcast as a live webinar in June 2023. Learn more about this webinar at https://mtechaccess.co.uk/market-access-for-digital-therapies/
Learn how Mtech Access can support you with your market access journey at: https://mtechaccess.co.uk/global-market-access-and-pricing/Subscribe to our newsletter to hear more news, insights and events from Mtech Access.
-
What does it take to bring a cannabinoid pharmaceutical to market?
We were delighted to welcome Michael Sassano (CEO â SOMAĂ Pharmaceuticals) as the first guest on our new Global Whispers webinar series. Michael shared with us his companyâs experiences bringing new products to market, the challenges SOMAĂ Pharmaceuticals have faced and the lessons the Pharma industry can learn from their journey.
In the webinar, Clare asked Michael about:
- Drug development and clinical trial processes for medical cannabis products
- Differences between the herbal medicines market and the Pharmaceutical market
- Overcoming regulatory and reimbursement challenges
- Finding the right place for cannabinoid medicines within existing pathways of care
- Perceptions, pathways and routes to access in different markets
- Lessons for the wider Pharma and Biotech industries
Learn more about this webinar and our guest speaker Michael Sassano at: https://mtechaccess.co.uk/global-market-access-journey-cannabinoid-pharmaceuticals/Subscribe to our newsletter to hear more news, insights and events from Mtech Access.
-
How will changes to the structure of primary care impact decision making?
The integration journey across primary careEvolving relationships and structures in primary care in the NHSWhere decisions are made and who makes themHow understanding commissioning priorities and funding flows can help Pharma and Medtech to identify decision makers and understand their needs
How is the relationship between Integrated Care Boards (ICBs) and primary care stakeholders evolving? How will funding flows be impacted?
Prof. Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) is joined by Tim Goodson (Executive Officer, Dorset General Practice Alliance) to explore how primary care is evolving and what this means for decision making, funding, and relationships with industry.
Phil and Tim explore:
This episode was first broadcast as a live webinar on Friday 28th April 2023.
For more information please see: https://mtechaccess.co.uk/primary-care-integration-journey/
Learn more about how Mtech Access UK NHS Insight services at: https://mtechaccess.co.uk/uk-nhs-insights/Subscribe to our newsletter to hear more news, insights and events from Mtech Access.
-
Is data the key to transforming healthcare systems and patient care?
What are the top priorities for digital transformation leaders in the NHS? How can Pharma and Medtech companies partner with the NHS to share data, transform services, and find smarter, faster way to improve patient care?
Prof. Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) is joined by Stephen Slough (Chief Digital Information Officer, NHS Dorset) to explore how, through the catalyst of partnership, new technologies and data have the potential to transform healthcare.
We have reached a point where digital is so ubiquitous that, even in the NHS, what were previously seen as âdigitalâ transformation projects are now viewed as simply business transformation projects.
Add in advancements in artificial intelligence and ChatGPT-type services, along with the potential of big data, and itâs no surprise that digital is at the heart of transformation in the NHS.
In this episode, Phil and Stephen explore:
- The digital landscape for NHS decision makers
- How, when and where data can transform healthcare systems and patient care
- How the NHS and industry can get access to and share our data to better plan products and services
- What the top priorities are for digital leaders
- How industry build strategic partnerships with Integrated Care Boards (ICBs) and other NHS leaders driving data-led transformation
This podcast was originally broadcast as a live webinar. Learn more at: https://mtechaccess.co.uk/data-led-transformation-nhs/
To learn more about our work with the NHS and how we support our Pharma and Medtech clients visit: https://mtechaccess.co.uk/uk-nhs-insights/Subscribe to our newsletter to hear more news, insights and events from Mtech Access.
-
How and where can innovation drive improvements in care and deliver better health for the population?
How is the NHS looking to collaborate with key partners across industry and academia? What innovations are set to transform care? What role do Academic Health Science Networks (AHSNs) play and how can partners best engage with them?
Prof Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) is joined by Bill Gillespie (Chief Executive Officer, Wessex AHSN) to explore innovation in the NHS, the role of AHSNs and the potential for greater collaboration across our sector, in our latest NHS Whispers webinar.
Learn more at: https://mtechaccess.co.uk/innovating-for-better-health/
The episode was was originally broadcast as a live webinar on 24th February 2023.
Discover our NHS Insights services and how we can support Medtech innovations achieve market access.Subscribe to our newsletter to hear more news, insights and events from Mtech Access.
-
Will NHS leaders, as part of an Integrated Care System (ICS), make conscious decisions to drive economic and social change?
What social and economic value do ICSs offer the wider population they serve? How will industry support ICSs to deliver population-based health and social benefits?Prof Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) is joined by Michael Wood (Head of Health Economic Partnerships, NHS Confed) for a far-reaching discussion around system integration, population health management, and the NHSâs social and economic potential.
NHS Confed and the links between the health sector and the economyThe need for ICS leaders to focus on broader social and economic developmentHow Pharma and Medical Device companies can add value to support this key ICS purposeWhy health and economic development is key to tackling health inequalitiesThe important role the NHS plays as an anchor institution that links better health with economic and social developmentWhat health and economic development could mean for funding at different levels of an integrated system â e.g. place based commissioningOpportunities for industry to step up and support the NHS with economic and social development
In December (2022), Michael Wood authored a report exploring one of the four key purposes of an ICS: to help the NHS support broader social and economic development. Michaelâs NHS Confed report looked at the economics of healthcare and where broader strategic partnership working might lead system thinking in the NHS.
Phil Richardson was one of several experienced ICS, local authority, university and professional experts that Michael invited to share their perspectives in the report.
We were delighted to bring Michael and Phil together in this webinar to discuss these topics, particularly in light of what these new leadership purposes mean for the NHSâs relationship with the Pharmaceutical and wider Life Science industries.
In the webinar, Phil and Michael discuss:Learn more about this webinar here
Learn more about our work with the NHS
This episode was first broadcast as a live webinar in January 2023Subscribe to our newsletter to hear more news, insights and events from Mtech Access.
- Show more
